# Explorative Study of AZD1305 in Atrial Fibrillation Patients

> **NCT00643448** · PHASE2 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 65 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

- **DRUG:** AZD1305
- **DRUG:** AZD1305
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00643448
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-08
- **Final completion:** 2008-08
- **Target enrollment:** 65 (ACTUAL)
- **Last updated:** 2012-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00643448

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00643448, "Explorative Study of AZD1305 in Atrial Fibrillation Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00643448. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*